Skip to main content
. Author manuscript; available in PMC: 2012 May 15.
Published in final edited form as: Clin Cancer Res. 2011 Apr 1;17(10):3349–3359. doi: 10.1158/1078-0432.CCR-10-3121

Table 2.

Differentially Expressed Glycoproteins Identified in Subjects with Bladder Cancer and Non-cancera

unique peptide No. expression
in cancer cases
frequency*


protein ID protein name p-value (FDR) non-cancer cancer non-cancer cancer
P01009 Alpha-1-antitrypsin < 0.01 20 20 up 0.87 0.98
P02787 Serotransferrin 0.04 20 25 up 0.62 0.91
P02790 Hemopexin 0.02 14 20 up 0.81 0.96
P07602 Proactivator polypeptide < 0.01 7 6 down 0.6 0.34
P07911 Uromodulin 0.08 19 16 down 0.91 0.7
P10451 Osteopontin 0.06 4 4 down 0.53 0.29
P16070 CD44 antigen 0.06 4 3 down 0.96 0.91
Q16769 Glutaminyl-peptide cyclotransferase < 0.01 6 3 down 0.51 0.2
Q9BY67 Cell adhesion molecule 1 < 0.01 5 4 down 0.51 0.2
a

Spectral counts of urinary glycoproteins with significantly differential abundance (FDR-value < 0.1).

*

The candidate must exist in more than half of the non-cancer or cancer samples to qualify as a potential marker.